aLF Reader and ImplantSafeDR test accurately detect damaging inflammation earlier than traditional methods to better protect dental implants
User defined application available on Beckman AU clinical chemistry analyzers for LiquiColor PCT assay enabling quick and effective sepsis identification
New Alinity testing solutions to help laboratories and hospitals achieve measurably better healthcare performance
Clinical scientists, your expertise is required! Review your equipment for your peers
Find out more about the Ansh Labs Glucagon Immunoassay Test for accurate and reliable glucagon detection
Stanford University chemists develop a synthetic solution to dwindling supplies of anti-cancer and HIV drugs extracted from marine creatures
Simple, safe and accurate results from a single drop of blood in minutes
Point-of-care technology allows clinicians to access vital results when they need them most
Dr. Aaron Overland from Essen BioScience answers all your webinar questions about quantitative live-cell analysis of neurons
Discover the application notes, scientific posters and compendiums being downloaded daily by clinical scientists
Learn about best practices for immune monitoring assays using xMAP® Technology from Luminex
Prof. Dr. Ger Rijkers tells SelectScience how he is using Luminex xMAP Technology® to develop a multiplex assay that can identify specific antibodies to multiple serotypes of S. pneumoniae in a single test
LiDia bloodstream infection test showcased at an Imperial College/Royal Institution Technology vs Infectious Diseases Summit in London
Revolutionary new chemistry analyzers said to offer flexibility, simplified workflow and tighter control gain CE Mark
Beckman Coulter to present at the European Society for Clinical Cell analysis (ESCCA) 2017
Screening for C. Difficile will reduce number of avoidable deaths, writes guest editor Gosia Leitch, Global Product Director with Alere
Dendritic cells are a key contributor to developing cancer vaccines
This exclusive interview reveals how Jackson have remained leaders in the secondary antibody market for over 30 years
David Rawling, PhD, discusses his work, his inspiration and his scientific heroes
